Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial - KIVIRID

Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trial

Authors: Cecilia Linde

Published: 2021-09-16

DOI: 10.1093/eurheartj/ehab695

Source: Full article

Abstract

No abstract found.